Thank you to all who have applied for this award. The submission site is now closed. Semi-finalists and finalists will be announced by May 25.
AACC’s Disruptive Technology Award recognizes innovative testing solutions that improve patient care through diagnostic performance or access to high quality testing.
The winning team will receive a cash prize and the opportunity to present their technology at the 70th AACC Annual Scientific Meeting, the premier international forum for unveiling groundbreaking advances in laboratory medicine.
Diagnostic developers with products ranging from the early to late stages of development are invited to apply, and companies or organizations of any size are welcome to enter the competition.
5 to 7 semi-finalists will receive complimentary full registrations for the AACC Annual Scientific Meeting, July 29 – August 2 in Chicago, where they will get valuable face time with leaders in the in vitro diagnostic industry and research communities. Each semi-finalist will also receive free AACC membership for up to 3 team members.
3 finalists will present data on their technology on Monday, July 30 from 4:30-6 p.m. During this session, a panel of expert judges will evaluate all presented testing solutions based on feasibility and performance. After the competition, all finalists will also have the opportunity to attend AACC's invitation-only Corporate Recognition Reception where they will be able to connect with leaders from top diagnostic companies.
The winner will be chosen at the end of the Monday, July 30 session and will receive a cash award, as well as free AACC membership for up to 5 team members, coverage by AACC, and an opportunity to present their technology to the laboratory medicine leaders in AACC's Chicago Local Section.
Who Can Apply?
All technology developers are eligible regardless of company/organization size, including in vitro diagnostic vendors and academic developers. Applicants should be able to present substantial data supporting an innovative technology that could significantly improve patient outcomes.